Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients

The proposed project aligns with our prior work targeting high-risk pediatric asthma
populations in non-inner city environments by targeting adolescents at risk for future
exacerbations from the Patient-Centered Medical Home (PCMH) at Arkansas Children's Hospital
(ACH).

We propose to conduct a 3-arm randomized, controlled trial with 372 adolescents with
uncontrolled asthma to test the effectiveness of mAAP. mAAP provides real-time, personalized
feedback, asthma education, and data logging/tracking capabilities.

Inclusion Criteria:

- Age ≥12 and <21 years

- Persistent asthma according to national guidelines criteria

- Asthma Control Test (ACT) score ≤19

- Prescribed a preventive (controller) asthma medication in the past 6 months

- Access to a smartphone compatible with the mAAP

- Access to the internet

- Able to read and speak English

Exclusion Criteria:

- Significant underlying respiratory disease other than asthma, such as cystic fibrosis

- Significant co-morbid conditions, such as moderate to severe developmental delay that
could interfere with the adolescent's ability to self-monitor asthma

- Current smoker

- Participation in the investigator's or other asthma clinical trials in the previous 6
months